Neurocrine Biosciences Inc.

NBIX | NASDAQ

Price Alert Chart Builder DCF Calculator

$145.89

-$0.21 (-0.14%)

Nov 2, 2026, 2:12 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023 Dec 31, 2023	Q3 2023 Sep 30, 2023	Q2 2023 Jun 30, 2023	Q1 2023 Mar 31, 2023	Q4 2022 Dec 31, 2022	Q3 2022 Sep 30, 2022	Q2 2022 Jun 30, 2022	Q1 2022 Mar 31, 2022	Q4 2021 Dec 31, 2021	Q3 2021 Sep 30, 2021	Q2 2021 Jun 30, 2021	Q1 2021 Mar 31, 2021
Revenue	3.37B	3.1B	2.86B	2.68B	2.51B	2.41B	2.36B	2.24B	2.12B	1.98B	1.89B	1.78B	1.67B	1.6B	1.49B	1.39B	1.3B	1.21B	1.13B	1.07B	1.03B	1.05B
Cost of Revenue	68.6M	56.7M	52.1M	43.8M	37.8M	35.7M	34M	33.2M	36.4M	38.7M	39.7M	38.9M	33.8M	27.1M	23.2M	19.6M	17.7M	16M	14.3M	13.1M	11.6M	10.9M
Gross Profit	3.31B	3.05B	2.81B	2.64B	2.47B	2.38B	2.32B	2.21B	2.08B	1.94B	1.85B	1.75B	1.64B	1.57B	1.47B	1.37B	1.28B	1.19B	1.12B	1.06B	1.02B	1.03B
Operating Income	788.9M	781.5M	619.1M	550.2M	495M	494.8M	570.5M	578.8M	536.2M	464.4M	250.9M	204M	150.6M	131.7M	249M	109.3M	66M	74.1M	102.5M	210.6M	121.8M	135.6M
Interest Income	7.5M	28.1M	21.7M	64.5M	42.3M	21.7M	n/a	n/a	n/a	12M	12M	12M	12M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	940.2M	937.5M	705.4M	628.6M	527.1M	466.2M	486M	521.6M	446.9M	469.9M	332.1M	251.8M	234.1M	89.2M	213.9M	82.2M	14.8M	95.6M	101.4M	156.9M	69.3M	95M
Net Income	705.5M	668.6M	478.6M	428M	348.3M	305.8M	341.3M	385.9M	339.2M	369.7M	249.7M	191M	176.4M	64M	154.5M	58.2M	12.2M	71.4M	89.6M	444.8M	364.7M	402M
Selling & General & Admin	1.35B	1.2B	1.16B	1.14B	1.08B	1.04B	1.01B	938.3M	908.2M	888M	887.6M	851.6M	833.7M	794.7M	752.7M	726.3M	694.6M	655M	583.3M	533.3M	491.2M	444.5M
Research & Development	1.13B	1.05B	1.02B	943.1M	888.1M	834.9M	731.1M	683M	630.2M	584.9M	565M	545.5M	511M	501.1M	463.8M	433.2M	418.2M	357.1M	328.1M	307.4M	283.8M	289.9M
Other Expenses	33.7M	17.3M	17.4M	3.4M	4.1M	6.6M	12.5M	9.5M	8.5M	6M	143.9M	143.9M	143.9M	143.9M	n/a	100.3M	100.3M	105.3M	105.3M	5M	123.5M	164.5M
Operating Expenses	2.52B	2.26B	2.19B	2.09B	1.98B	1.88B	1.75B	1.63B	1.55B	1.48B	1.6B	1.54B	1.49B	1.44B	1.22B	1.26B	1.21B	1.12B	1.02B	845.7M	898.5M	898.9M
Interest Expense	2.9M	n/a	n/a	n/a	n/a	49.7M	50.8M	51.9M	53M	4.6M	4.6M	4.6M	4.7M	5.6M	7.1M	12.6M	18M	22M	25.8M	27M	28.9M	31M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	2.59B	2.32B	2.24B	2.13B	2.01B	1.92B	1.78B	1.66B	1.58B	1.52B	1.64B	1.58B	1.52B	1.47B	1.24B	1.28B	1.23B	1.13B	1.03B	858.8M	910.1M	909.8M
Income Tax Expense	234.7M	268.9M	226.8M	200.6M	178.8M	160.4M	144.7M	135.7M	107.7M	100.2M	82.4M	60.8M	57.7M	25.2M	59.4M	24M	2.6M	24.2M	11.8M	-287.9M	-295.4M	-307M
Shares Outstanding (Basic)	101M	100.5M	99.5M	99.4M	99M	99.7M	100M	101.1M	100.8M	99.8M	98.4M	97.9M	97.6M	97.1M	96.3M	95.8M	95.6M	95.3M	94.9M	94.7M	94.6M	94.2M
Shares Outstanding (Diluted)	104.2M	103.4M	102.5M	102.5M	101M	102.5M	102.9M	104.3M	103.9M	103.6M	102.3M	101.1M	100.2M	97.1M	100.8M	99M	95.6M	97.6M	94.9M	97.7M	97.7M	98.2M
EPS (Basic)	7.05	6.71	4.82	4.31	3.48	3.03	3.38	3.85	3.42	3.76	2.54	1.96	1.83	0.67	1.61	0.61	0.13	0.76	0.95	4.75	3.89	4.30
EPS (Diluted)	6.82	6.49	4.66	4.18	3.38	2.95	3.29	3.73	3.31	3.63	2.42	1.86	1.73	0.60	1.53	0.57	0.11	0.72	0.91	4.57	3.72	4.10
EBITDA	918.1M	895M	733M	679.3M	571.1M	559.5M	639.7M	663M	593.9M	565.4M	356.7M	275.1M	256M	112.1M	236.6M	109M	45.8M	129.3M	138.1M	194M	107.7M	135M
EBIT	870.8M	865.2M	702.9M	649.6M	542.6M	531M	612.6M	637.3M	569.2M	542.9M	335.4M	255.1M	237.5M	94.8M	221M	94.8M	32.8M	117.6M	127.2M	183.9M	98.2M	126M
Depreciation & Amortization	47.3M	29.8M	30.1M	29.7M	28.5M	28.5M	27.1M	25.7M	24.7M	22.5M	21.3M	20M	18.5M	17.3M	15.6M	14.2M	13M	11.7M	10.9M	10.1M	9.5M	9M